Pathologic changes associated with use of tribromoethanol (avertin) in the Sprague Dawley rat.
Reid
W C
WC
Institute of Human Virology, Animal Model Division, Baltimore, Maryland, USA.
Carmichael
K P
KP
Srinivas
S
S
Bryant
J L
JL
D000777:Anesthetics / Q000633:toxicity*; D000818:Animals; D000431:Ethanol / Q000031:analogs & derivatives* / Q000633:toxicity; D005260:Female; D007274:Injections, Intraperitoneal; D007410:Intestinal Diseases / Q000139:chemically induced / Q000473:pathology*; D008103:Liver Cirrhosis / Q000139:chemically induced / Q000473:pathology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012185:Retroperitoneal Fibrosis / Q000139:chemically induced / Q000473:pathology*; D013158:Splenic Diseases / Q000139:chemically induced / Q000473:pathology*
D000777:Anesthetics; C062527:tribromoethanol; D000431:Ethanol